Tissue Regenix

France
Anneyron, Rhône-Alpes, France, YO10 5NY

Company profile

Tissue Regenix company profile

Tissue Regenix commercializes innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. Tissue Regenix was founded in May 2006, to commercialize innovative technologies in regenerative medicine.

Business identity

Contact email
[email protected]
Phone number
+44 1904 567609
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2006-05-01

Headquarters

Postal code
YO10 5NY
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
4
Total equity funding
$19.1M
Last funding
Post IPO Debt / $10.1M / 2025-12-22
Last equity funding
Post IPO Equity / $17.8M
Investors
5
Lead investors
2
Founders
2
Articles
58
Exited on
2010-06-29

Founders and investors

Founders

Eileen InghamJohn Fisher

Lead investors

Harwood Private EquityMidCap Financial

Investors

Aquarius Equity PartnersHarwood Private EquityIP GroupMidCap FinancialWhite Rose Technology Seedcorn Fund